checkAd

    EQS-News  105  0 Kommentare Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success

    Für Sie zusammengefasst
    • EBITDA up 32.4% to EUR 81.4 million
    • Specialty chemicals drive earnings growth
    • Dividend increase to EUR 1.20 planned

    EQS-News: Alzchem Group AG / Key word(s): Annual Report/Annual Results
    Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success

    01.03.2024 / 07:00 CET/CEST
    The issuer is solely responsible for the content of this announcement.


    Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success

    • High-growth specialty chemicals business proves to be a key earnings driver and important sales pillar
    • Dividend increase to EUR 1.20 planned
    • Forecast for 2024 envisages rise in sales and EBITDA

    Trostberg, March 1, 2024 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, can look back on a successful fiscal year 2023. Despite a persistently challenging environment, the company succeeded in significantly increasing all key earnings figures and at EUR 540.6 million (2022: EUR 542.2 million) maintaining Group sales almost at the previous year’s record level. Alzchem was thus able to successfully decouple itself from the development of the chemical industry in Germany. The consistent transformation towards specialty chemicals proved to be a key success factor. In this growth segment, the company benefits disproportionately from its unique position with numerous products such as Creapure, Creamino and guanidine salts. In addition, the cost structure for specialty chemicals is less dominated by the price of electricity. As a result, the Specialty Chemicals segment recorded sales growth of 10.9%, largely offsetting the volume- and price-driven sales decline of 15.5% in the Basics & Intermediates segment.

    Primarily due to the increasing weight of the higher-margin growth segment Specialty Chemicals, Alzchem succeeded in significantly increasing Group EBITDA by 32.4% to EUR 81.4 million in the fiscal year 2023 (previous year: EUR 61.4 million). This results in a significantly improved EBITDA margin of 15.1% after 11.3% in the previous year. The decision not to pursue a low-price strategy in the electricity-intensive Basics & Intermediates segment and a slightly lower cost level also contributed to this extremely positive earnings performance. Consolidated net profit grew by 15.1% to EUR 34.8 million (previous year: EUR 30.2 million) and led to a significant increase in the Group equity ratio to 38.5% as of December 31, 2023 (December 31, 2022: 34.5%). Due to the very pleasing earnings performance, the Management Board and Supervisory Board will propose to the Annual General Meeting on May 7, 2024 that a dividend of EUR 1.20 (previous year: EUR 1.05) per share be distributed from the balance sheet profit.

    Seite 1 von 4


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-News Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success EQS-News: Alzchem Group AG / Key word(s): Annual Report/Annual Results Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success 01.03.2024 / 07:00 CET/CEST The issuer is solely responsible for the content …